Samuel Ryan Jacobson (born July 22, 1975) is an American former professional basketball player. He played professionally for the NBA's Los Angeles Lakers,...
Darex, Llc
Production Engineer
Brammo Mar 2012 - Feb 2014
Production Engineer
Timbercon, Inc. Jul 2010 - Mar 2012
Process Engineer
Timbercon, Inc. Sep 2009 - Jun 2010
Engineering Intern
Education:
University of Oregon 2009 - 2010
Masters, Applied Physics
Oregon Institute of Technology 2004 - 2009
Bachelors, Bachelor of Science
Skills:
Internal Auditor Doe Solidworks Fiber Optics Optics Lean Manufacturing Manufacturing Failure Analysis Design of Experiments Manufacturing Engineering Product Development Optical Engineering Spectroscopy Test Equipment Troubleshooting Optical Fiber Rf Electrical Engineering Engineering Iso Systems Engineering Sensors Vehicles Physics Quality System As9100 Fmea
Scheie Eye Institute 51 N 39 St STE 1, Philadelphia, PA 19104 2156628100 (phone), 2156620240 (fax)
Education:
Medical School University of Illinois, Chicago College of Medicine Graduated: 1970
Procedures:
Ophthalmological Exam
Conditions:
Cataract Macular Degeneration
Languages:
English
Description:
Dr. Jacobson graduated from the University of Illinois, Chicago College of Medicine in 1970. He works in Philadelphia, PA and specializes in Ophthalmology. Dr. Jacobson is affiliated with Hospital Of The University Of Pennsylvania and Penn Presbyterian Medical Center.
Dr. Jacobson graduated from the University of Oklahoma College of Medicine at Oklahoma City in 1977. He works in Jefferson City, TN and 1 other location and specializes in Pulmonary Critical Care Medicine. Dr. Jacobson is affiliated with Jefferson Memorial Hospital, Physicians Regional Medical Center and Turkey Creek Medical Center.
Beltran, in collaboration with Artur Cideciyan, Ph.D. and Samuel Jacobson, M.D., Ph.D., University of Pennsylvania Scheie Eye Institute, Gustavo Aguirre, V.M.D., Ph.D., University of Pennsylvania School of Veterinary Medicine, and Alfred Lewin, Ph.D., and William Hauswirth, Ph.D., University of Flor
Date: Aug 21, 2018
Category: Headlines
Source: Google
Gene therapy shows promise for inherited eye disease
permanent: researchers said the gains began to diminish after one to three years."Gene therapy for LCA demonstrated we could improve vision in previously untreatable and incurable retinal conditions," study leader Dr. Samuel Jacobson, of the University of Pennsylvania's Scheie Eye Institute, said in a U.S.
Two years ago, however, a team led by Samuel Jacobson at the University of Pennsylvania (UPenn), which runs one of the U.S. trials for LCA, sounded a note of caution: They reported that although their 15 patients who had regained some vision could still see better, their photoreceptor cells were con
Date: May 04, 2015
Category: Health
Source: Google
Gene Therapy Could Provide Benefit to Certain Vision Impairment
Gene therapy for LCA demonstrated we could improve vision in previously untreatable and incurable retinal conditions, explins study leader Dr. Samuel Jacobson, with the University of Pennsylvanias Scheie Eye Institute.
Date: May 04, 2015
Category: Health
Source: Google
Gene Therapy Could Be A Solution For Inherited Blindness, Study Suggests
Dr. Samuel Jacobson, from the University of Pennsylvanias Scheie Eye Institute, in Philadelphia, said that these results are an important step towards efficient cure for both inherited blindness and other diseases of the retina, even though the therapy does not appear to be a permanent treatment.